The microbiome has been called the second human genome. It is shaped by how we were born, where we live and the foods and medicines we are given in childhood. In recent years, there has been an explosion in the number of scientific studies regarding the role of the gut microbiome in metabolic, allergic and autoimmune diseases. Therapeutic implications of altering the microbiome to alter disease states have taken shape and form an exciting new frontier of medicine.
This activity will use case-based scenarios to illustrate different patterns of liver test abnormalities. Dr. Han from the Dumont-UCLA Liver Transplant Center will discuss the difference between cholestatic versus hepatitis versus infiltrative liver diseases and their characteristic liver test patterns. Additionally, he will review the subsequent work-up of liver test abnormalities which are followed by supplemental serological testing, imaging, and in some cases, liver biopsy. He will also summarize the difference between true “liver function tests”, tests of cholestasis, tests of inflammation, and tests of infiltration.
In this activity, Dr. Pandolfino will discuss frequently asked questions on esophageal dysphagia. He will review the finer points of diagnosing dysphagia and discuss different avenues and strategies for treating and managing dysphagia in your patients.
Eosinophilic esophagitis (EoE) is a potentially serious inflammatory condition that can result in ED visits for food impaction and can severely impact quality of life for patients. Nirmala Gonsalves, MD, of Northwestern’s Fineberg School of Medicine reviews the symptoms, diagnosis, and treatment of EoE, and provides tips for long-term control of this condition.
This activity offers expert insight into types of dietary fiber, their mechanisms of action in the body, beneficial impacts on cardiometabolic and digestive health, and how primary care providers can incorporate fiber counseling into their clinical practice.
In this activity, Dr. Damas will review the phenotypic manifestations and extra-intestinal manifestations of inflammatory bowel diseases, including Crohn’s and ulcerative colitis. She will explain what we currently know about disease pathogenesis, including the influence of genetics and the environment on the microbiome and finally, discuss some of the latest updates on treatment of IBD.
Nonalcoholic fatty liver (NAFL) is an emerging concern among a subset of the diabetic and obese population. Complications arise when the disease progresses to nonalcoholic steatohepatitis (NASH) and cirrhosis. It is important for the primary care physician to recognize the hallmarks of NAFLD and the progression to NASH. Here, Dr. Chopra discusses strategies for diagnosis, treatment and management of patients with this hepatic disorder.
This activity will review the presenting features, diagnostic tests and management of patients with celiac disease. Dr. Leffler will discuss diagnostic problems and common issues that affect treatment and review the long term complications associated with celiac disease. He will also review available information on gluten sensitivity and discuss how the two disorders overlap.
Apply new guidelines for the diagnosis of these digestive disorders, and recommend dietary adjustments as indicated.
This activity provides an update on the diagnostic criteria for functional bowel disorders, including irritable bowel syndrome (IBS). The activity gives information on how to differentiate between IBS and other bowel disorders like microscopic colitis, celiac disease, colorectal cancer, and inflammatory bowel disease. It also discusses lifestyle and dietary interventions for managing IBS and includes a section on non-celiac gluten sensitivity and the FODMAP diet.